Affinity Asset Advisors’s Vincerx Pharma, Inc. Warrant VINCW Stock Holding History

Affinity Asset Advisors’s Portfolio VINCW Stock Details VINCW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-218,000	Closed	-$881K	–	86
2021 Q1	$881K	Buy	218,000 +28,000	+15%	+$113K	0.3%	50
2020 Q4	$627K	Buy	+190,000	New	+$632K	0.33%	54

Affinity Asset Advisors's VINCW Position: Q2 2021 in Review

Affinity Asset Advisors sold out of Vincerx Pharma, Inc. Warrant (VINCW) in Q2 2021, closing a stake of 218,000 shares — an estimated $881K sold.

Affinity Asset Advisors first reported a position in VINCW in Q4 2020 and held it in 2 quarters. The position peaked at $881K in Q1 2021. 0 funds tracked by Wall St. Rank hold VINCW as of Q2 2021.

Affinity Asset Advisors reported no remaining Vincerx Pharma, Inc. Warrant position as of Q2 2021 after selling out during the quarter.
Affinity Asset Advisors sold 218,000 Vincerx Pharma, Inc. Warrant shares in Q2 2021, an estimated $881K.
Affinity Asset Advisors first reported a position in Vincerx Pharma, Inc. Warrant in Q4 2020 and held it in 2 quarters.
Affinity Asset Advisors's Vincerx Pharma, Inc. Warrant position peaked at $881K in Q1 2021.
0 funds tracked by Wall St. Rank held Vincerx Pharma, Inc. Warrant as of Q2 2021.

Based on Affinity Asset Advisors's 13F filing for Q2 2021, filed 13 Aug 2021.